Novel Insights into Leukemogenesis

Bidragets beskrivning

We have very recently identified the first predisposing gene for a specific type of acute myeloid leukemia (AML). We have demonstrated that a homozygous mutation in ERCC6L2 gene causes AML with distinct characteristics. We have shown that individuals with the bi-allelic mutations develope AML with erythroid predominance and very poor prognosis. Hence, ERCC6L2 defines a novel entity within inherited acute myeloid leukemia. We will provide new insights into leukemogenesis and normal hematopoiesis focusing on the specific features of ERCC6L2 defect-driven leukemia. Furthermore, we will gain deeper understanding in normal hematopoiesis.
Visa mer

Startår

2022

Slutår

2026

Beviljade finansiering

Outi Kilpivaara Orcid -palvelun logo
500 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Övriga uppgifter

Finansieringsbeslutets nummer

349760

Vetenskapsområden

Genetik, utvecklingsbiologi, fysiologi

Forskningsområden

Perinnöllisyystiede

Identifierade teman

cancer